数字农科院2.0

Safety study of fluralaner solution on poultry red mite: A clinical study screening of the optimal dose and focusing on hepatic and renal parameters

文献类型： 外文期刊

作者： Tingting Sun;Hao Wu;Jing Liu;Lin Jiang;Xinyu Wang;Fei Xu;Xiubo Li

作者机构：

关键词： Efficacy evaluation;Fluralaner solution;Poultry red mite;Safety evaluation

期刊名称： Poultry Science

ISSN： 0032-5791

年卷期： 2025 年 104 卷 2 期

页码：

收录情况： SCIE（2025版）

摘要： The poultry red mite (PRM), Dermanyssus gallinae, a significant ectoparasite causing diseases in poultry, is globally prevalent and necessitates effective control strategies. There are restrictions on the use of acaricides in poultry across several nations due to worries about medication residues. Consequently, finding safe and efficient treatments for PRM is imperative. Fluralaner solution has emerged as a potential therapeutic agent, distinguished by its rapid onset, enduring efficacy, and lack of a withdrawal period for egg production. To ascertain the optimal dosage and therapeutic efficacy of fluralaner solution in PRM treatment, this study evaluated blood biochemical parameters and mite populations across various treatment groups. A cohort of 500 laying hens was randomly assigned to one of five treatment groups, each comprising 100 individuals:high-dose group (0.1 ml/kg-bw, group 4 ×, coop 1), medium-dose group (0.05 ml/kg-bw, group 2 ×, coop 5), low-dose group (0.025 ml/kg-bw, group 1 ×, coop 2), drug-control group (Intervet Productions, 0.05 ml/kg-bw recommended dose, coop 3) and blank control group (coop 4). Hens received their respective dosages of the fluralaner solution via oral administration on Days 0 (D0) and 7 (D7) of the experimental period. Over the study's ninety days, blood biochemical markers and mite counts in each coop were measured to evaluate the drug's safety, effectiveness, and ideal dosage. Data analysis was performed utilizing SPSS software. The study findings indicated that, for effective PRM infestation treatment, a dosage of 0.5 mg fluralaner per kilogram of body weight (equivalent to 0.05 ml) administered daily, followed by a subsequent dose post a 7-day interval, is recommended. Additionally, clinical observations coupled with blood biochemical assessments confirmed the safety of fluralaner across the three tested dosage levels in hens.

分类号：

  • 相关文献

[1]Diagnostic Efficacy of Plasma-Based Real-Time PCR for Schistosomiasis Japonica in Mice before and after Treatment with Praziquantel. Cheng Chen,Xue Zhou,Qinghong Guo,Chao Lv,Yalan Tang,Qingqing Guo,Yang Chen,Kerou Zhou,Zhiqiang Fu,Jinming Liu,Jiaojiao Lin,Yang Hong,Jun Hu Chen. 2023

[2]Dissipation, residues, and safety evaluation of trifloxystrobin and tebuconazole on ginseng and soil. Wang, Yan,Gao, Jie,Liu, Chang,Wang, Chunwei,Cui, Lili,Li, Aijun.

[3]Safety evaluation of daidzein in laying hens: Part I. Effects on laying performance, clinical blood parameters, and organs development. Shi, S. R.,Gu, H.,Chang, L. L.,Tong, H. B.,Zou, J. M.,Gu, H.,Wang, Z. Y.. 2013

[4]Safety evaluation of daidzein in laying hens: Part II. Effects on calcium-related metabolism. Gu, H.,Shi, S. R.,Chang, L. L.,Tong, H. B.,Zou, J. M.,Gu, H.,Wang, Z. Y.. 2013

[5]Safety evaluation of phytosterols in laying hens: Effects on laying performance, clinical blood parameters, and organ development. Shi, S. R.,Shen, Y. R.,Chang, L. L.,Bo, Z.,Tong, H. B.,Zou, J. M.,Zhou, C. J.,Wang, Z. Y.. 2014

[6]Safety evaluation of daidzein in laying hens: Effects on laying performance, hatchability, egg quality, clinical blood parameters, and organ development. Lu, J.,Qu, L.,Shen, M. M.,Li, S. M.,Dou, T. C.,Hu, Y. P.,Wang, K. H..

[7]Agricultural GMO safety administration in China. Kou Jian-ping,Zhang Xian-fa,Tang Qiao-ling. 2015

[8]Risk assessment of predatory lady beetle Propylea japonica's multi-generational exposure to three non-insecticidal agrochemicals. Guofeng Chang,Hui Xue,Jichao Ji,Li Wang,Xiangzhen Zhu,Kaixin Zhang,Dongyang Li,Xueke Gao,Lin Niu,Mengxue Gao,Junyu Luo,Jinjie Cui. 2023

[9]Identification and Genetic Characterization of a Strain of African Horse Sickness Virus Serotype 1 and Its Safety Evaluation in a Mouse Model. Min Zhang,Xue Feng Wang,Si Fan Guo,Lei Wang,Bo Fan Fu,Jing Wen Wang,Ya Fen Song,Xiao Yue Yang,Si Yuan Hao,Qian Yi Zhang,Bing Zhang,Cheng Huai Yang. 2025

[10]Screening of Positive Controls for Environmental Safety Assessment of RNAi Products. Ding, Kaixuan,Yang, Xiaowei,Zhou, Qinli,Chen, Geng,Chen, Fengping,Tan, Yao,Li, Jing,Han, Lanzhi. 2025

作者其他论文 更多>>